The Patient Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.
Brendan C. Visser, MD
Hepatobiliary surgeon, Pancreatic surgeon, Surgical oncologist
Associate Professor of Surgery (General Surgery) at the Stanford University Medical Center
Bio:
Dr. Visser is a native of San Francisco, the youngest of eight children. He attended Deep Springs College in Eastern California and then went on to earn his BS at Cornell University in Ithaca NY. After receiving his MD degree at the University of California - San Francisco, he stayed at UCSF for his residency training in general surgery. He then completed specialized fellowship training in hepatobiliary and pancreatic surgery (also called HPB surgery) at the University of Edinburgh in Ediburgh, UK. Dr. Visser is board certified in general surgery by the American Board of Surgery. His principle practice is at Stanford Hospital and the Stanford Cancer Center, but he is also a staff surgeon at the Veterans Affairs Palo Alto Health Care System, serving our veteran patients.
Dr. Visser is actively involved in the General Surgery training program and is the program director for the Stanford Hepatopancreatobiliary (HPB) Surgery fellowship program. Dr. Visser was honored in 2011 with the John Collins Memorial Teaching Award, an annual faculty recognition selected by the entire body of general surgery residents. He also received the Best Rotation Award in 2015, which is selected by Stanford chief residents in general surgery. He is the Medical Director of the GI Cancer Care Program at the Stanford Cancer Center.
Dr. Visser is actively involved in the General Surgery training program and is the program director for the Stanford Hepatopancreatobiliary (HPB) Surgery fellowship program. Dr. Visser was honored in 2011 with the John Collins Memorial Teaching Award, an annual faculty recognition selected by the entire body of general surgery residents. He also received the Best Rotation Award in 2015, which is selected by Stanford chief residents in general surgery. He is the Medical Director of the GI Cancer Care Program at the Stanford Cancer Center.
- 875 Blake Wilbur Drive
- Palo Alto , CA 94304
- Phone: 650-498-6000
- 900 Blake Wilbur Drive
- 2nd Floor
- Palo Alto , CA 94304
- Phone: 650-498-6000
- 420 Broadway Street, Pavilion D, 2nd Floor
- Redwood City , CA 94063
- Phone: 650-736-5555
Practice Areas
Professional Education
- Residency: Univ of California San Francisco (2005) CA
- Medical Education: Univ of California San Francisco (1999) CA
- Fellowship: University of Edinburgh; Edinburgh Royal (2006)
- Board Certification: General Surgery, American Board of Surgery (2006)
- MD, Univ. of Calif., San Francisco, Medicine (1999)
- Resident, Univ. Of Calif., San Francisco, General Surgery (2005)
- Fellow, Univ. of Edinburgh, UK, Hepatobiliary/Pancreatic Surgery (2006)
Honors & Awards
- Best Rotation Award: Stanford Chief Residents 2015, Stanford General Surgery Residency (2014-2015)
- John Collins Memorial Teaching Award, Annual faculty teaching award selected by entire body of general surgery residents (2010-2011)
Administrative Appointments
- Medical Director, Gastrointestinal Cancer Care Program, Stanford Cancer Center (2015 - Present)
- Program Director, HPB Fellowship, Stanford HPB Program (2013 - Present)
Publications
-
Safety and timing of nonobstetric abdominal surgery in pregnancy
Visser, B. C., Glasgow, R. E., Mulvihill, K. K., & Mulvihill, S. J. (2001). Safety and timing of nonobstetric abdominal surgery in pregnancy. DIGESTIVE SURGERY, 18(5), 409–417. -
Adjuvant and neoadjuvant therapy for esophageal cancer: a critical reappraisal
Visser, B. C., Venook, A. P., & Patti, M. G. (2003). Adjuvant and neoadjuvant therapy for esophageal cancer: a critical reappraisal. SURGICAL ONCOLOGY-OXFORD, 12(1), 1–7. -
Diagnostic imaging of cystic pancreatic neoplasms
Visser, B. C., Muthusamay, V. R., Mulvihill, S. J., & Coakley, F. (2004). Diagnostic imaging of cystic pancreatic neoplasms. SURGICAL ONCOLOGY-OXFORD, 13(1), 27–39. -
Congenital choledochal cysts in adults
Visser, B. C., Suh, I., Way, L. W., & Kang, S. M. (2004). Congenital choledochal cysts in adults. ARCHIVES OF SURGERY, 139(8), 855–860.
-
The influence of portoenterostomy on transplantation for biliary atresia
Visser, B. C., Suh, I., Hirose, S., Rosenthal, P., LEE, H., Roberts, J. P., & Hirose, R. (2004). The influence of portoenterostomy on transplantation for biliary atresia. LIVER TRANSPLANTATION, 10(10), 1279–1286.
-
Characterization of cystic pancreatic masses: Relative accuracy of CT and MRI
Visser, B. C., Yeh, B. M., Qayyum, A., Way, L. W., McCulloch, C. E., & Coakley, F. V. (2007). Characterization of cystic pancreatic masses: Relative accuracy of CT and MRI. AMERICAN JOURNAL OF ROENTGENOLOGY, 189(3), 648–656.
-
Open cholecystectomy in the laparoendoscopic era
Visser, B. C., Parks, R. W., & Garden, O. J. (2008). Open cholecystectomy in the laparoendoscopic era. AMERICAN JOURNAL OF SURGERY, 195(1), 108–14.
-
Diagnostic evaluation of cystic pancreatic lesions
Visser, B. C., Muthusamy, V. R., Yeh, B. M., Coakley, F. V., & Way, L. W. (2008). Diagnostic evaluation of cystic pancreatic lesions. HPB, 10(1), 63–69.
-
A NOVEL PRKAR1A MUTATION ASSOCIATED WITH PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE AND THE CARNEY COMPLEX
Peck, M. C., Visser, B. C., Norton, J. A., Pasche, L., & Katznelson, L. (2010). A NOVEL PRKAR1A MUTATION ASSOCIATED WITH PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE AND THE CARNEY COMPLEX. ENDOCRINE PRACTICE, 16(2), 198–204.
-
Death After Colectomy It's Later Than We Think
Visser, B. C., Keegan, H., Martin, M., & Wren, S. M. (2009). Death After Colectomy It's Later Than We Think. ARCHIVES OF SURGERY, 144(11), 1021–27.
-
Comparison of Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy as Adjuvant Therapy for Gastric Cancer
Minn, A. Y., Hsu, A., La, T., Kunz, P., Fisher, G. A., Ford, J. M., … Chang, D. T. (2010). Comparison of Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy as Adjuvant Therapy for Gastric Cancer. CANCER, 116(16), 3943–52.
-
Expression of p16(INK4A) But Not Hypoxia Markers or Poly Adenosine Diphosphate-Ribose Polymerase Is Associated With Improved Survival in Patients With Pancreatic Adenocarcinoma
Chang, D. T., Chapman, C. H., Norton, J. A., Visser, B., Fisher, G. A., Kunz, P., … Pai, R. K. (2010). Expression of p16(INK4A) But Not Hypoxia Markers or Poly Adenosine Diphosphate-Ribose Polymerase Is Associated With Improved Survival in Patients With Pancreatic Adenocarcinoma. CANCER, 116(22), 5179–87.
-
Predictors of Surgical Intervention for Hepatocellular Carcinoma
Zak, Y., Rhoads, K. F., & Visser, B. C. (2011). Predictors of Surgical Intervention for Hepatocellular Carcinoma. ARCHIVES OF SURGERY, 146(7), 778–84.
-
Ruptured Biliary Cystadenoma Managed by Angiographic Embolization and Interval Partial Hepatectomy
Ghole, S. A., Bakhtary, S., Staudenmayer, K., Sze, D. Y., Pai, R. K., Visser, B. C., … Poultsides, G. A. (2011). Ruptured Biliary Cystadenoma Managed by Angiographic Embolization and Interval Partial Hepatectomy. DIGESTIVE DISEASES AND SCIENCES, 56(7), 1949–53.
-
Pancreatic Endocrine Tumors With Major Vascular Abutment, Involvement, or Encasement and Indication for Resection
Norton, J. A., Harris, E. J., Chen, Y., Visser, B. C., Poultsides, G. A., Kunz, P. C., … Jensen, R. T. (2011). Pancreatic Endocrine Tumors With Major Vascular Abutment, Involvement, or Encasement and Indication for Resection. ARCHIVES OF SURGERY, 146(6), 724–32.
-
Adult Intestinal Malrotation: When Things Turn the Wrong Way
Palmer, O. P., Rhee, H. H., Park, W. G., & Visser, B. C. (2012). Adult Intestinal Malrotation: When Things Turn the Wrong Way. DIGESTIVE DISEASES AND SCIENCES, 57(2), 284–87.
-
Single-cell dissection of transcriptional heterogeneity in human colon tumors
Dalerba, P., Kalisky, T., Sahoo, D., Rajendran, P. S., Rothenberg, M. E., Leyrat, A. A., … Quake, S. R. (2011). Single-cell dissection of transcriptional heterogeneity in human colon tumors. NATURE BIOTECHNOLOGY, 29(12), 1120–U11.
-
Abdominal Mass, Anemia, Diabetes Mellitus, and Necrolytic Migratory Erythema
Qadan, M., Visser, B., Kim, J., Pai, R., & Triadafilopoulos, G. (2012). Abdominal Mass, Anemia, Diabetes Mellitus, and Necrolytic Migratory Erythema. DIGESTIVE DISEASES AND SCIENCES, 57(6), 1465–68.
-
Sump Syndrome as a Complication of Choledochoduodenostomy
Qadan, M., Clarke, S., Morrow, E., Triadafilopoulos, G., & Visser, B. (2012). Sump Syndrome as a Complication of Choledochoduodenostomy. DIGESTIVE DISEASES AND SCIENCES, 57(8), 2011–15.
-
Video-assisted thoracoscopic transdiaphragmatic liver resection for hepatocellular carcinoma
Cloyd, J. M., & Visser, B. C. (2012). Video-assisted thoracoscopic transdiaphragmatic liver resection for hepatocellular carcinoma. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 26(6), 1772–76.
-
Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma
Abelson, J. A., Murphy, J. D., Minn, A. Y., Chung, M., Fisher, G. A., Ford, J. M., … Chang, D. T. (2012). Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 82(4), E595–E601.
-
Diagnostic accuracy of cyst fluid amphiregulin in pancreatic cysts
Tun, M. T., Pai, R. K., Kwok, S., Dong, A., Gupta, A., Visser, B. C., … Park, W. G. (2012). Diagnostic accuracy of cyst fluid amphiregulin in pancreatic cysts. BMC GASTROENTEROLOGY, 12.
-
Preoperative embolization of replaced right hepatic artery prior to pancreaticoduodenectomy
Cloyd, J. M., Chandra, V., Louie, J. D., Rao, S., & Visser, B. C. (2012). Preoperative embolization of replaced right hepatic artery prior to pancreaticoduodenectomy. JOURNAL OF SURGICAL ONCOLOGY, 106(4), 509–12.
-
Pancreatic Neuroendocrine Tumors: Radiographic Calcifications Correlate with Grade and Metastasis
Poultsides, G. A., Huang, L. C., Chen, Y., Visser, B. C., Pai, R. K., Jeffrey, R. B., … Norton, J. A. (2012). Pancreatic Neuroendocrine Tumors: Radiographic Calcifications Correlate with Grade and Metastasis. ANNALS OF SURGICAL ONCOLOGY, 19(7), 2295–2303.
-
Changes in spleen volume after resection of hepatic colorectal metastases
Jacobs, K. E., Visser, B. C., & Gayer, G. (2012). Changes in spleen volume after resection of hepatic colorectal metastases. CLINICAL RADIOLOGY, 67(10), 982–87.
-
The Epidemiology of Idiopathic Acute Pancreatitis, Analysis of the Nationwide Inpatient Sample From 1998 to 2007
Chen, Y., Zak, Y., Hernandez-Boussard, T., Park, W., & Visser, B. C. (2013). The Epidemiology of Idiopathic Acute Pancreatitis, Analysis of the Nationwide Inpatient Sample From 1998 to 2007. PANCREAS, 42(1), 1–5.
-
Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes
Visser, B. C., Ma, Y., Zak, Y., Poultsides, G. A., Norton, J. A., & Rhoads, K. F. (2012). Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes. HPB, 14(8), 539–47.
-
Lymph Nodes and Survival in Pancreatic Neuroendocrine Tumors
Krampitz, G. W., Norton, J. A., Poultsides, G. A., Visser, B. C., Sun, L., & Jensen, R. T. (2012). Lymph Nodes and Survival in Pancreatic Neuroendocrine Tumors. ARCHIVES OF SURGERY, 147(9), 820–27.
-
Seventh Edition (2010) of the AJCC/UICC Staging System for Gastric Adenocarcinoma: Is there Room for Improvement?
Patel, M. I., Rhoads, K. F., Ma, Y., Ford, J. M., Visser, B. C., Kunz, P. L., … Poultsides, G. A. (2013). Seventh Edition (2010) of the AJCC/UICC Staging System for Gastric Adenocarcinoma: Is there Room for Improvement? ANNALS OF SURGICAL ONCOLOGY, 20(5), 1631–38.
-
Neoadjuvant Imatinib for Borderline Resectable GIST
Koontz, M. Z., Visser, B. M., & Kunz, P. L. (2012). Neoadjuvant Imatinib for Borderline Resectable GIST. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 10(12), 1477–82.
-
Hospital readmission after a pancreaticoduodenectomy: an emerging quality metric?
Kastenberg, Z. J., Morton, J. M., Visser, B. C., Norton, J. A., & Poultsides, G. A. (2013). Hospital readmission after a pancreaticoduodenectomy: an emerging quality metric? HPB, 15(2), 142–48.
-
Complete resection of a rare intrahepatic variant of a choledochal cyst
Salles, A., Kastenberg, Z. J., Wall, J. K., Visser, B. C., & Bruzoni, M. (2013). Complete resection of a rare intrahepatic variant of a choledochal cyst. JOURNAL OF PEDIATRIC SURGERY, 48(3), 652–54.
-
Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine.
Park, W. G., Wu, M., Bowen, R., Zheng, M., Fitch, W. L., Pai, R. K., … Peltz, G. (2013). Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine. Gastrointestinal Endoscopy, 78(2), 295–302 e2.
-
Diagnostic Utility of Metabolomic-Derived Biomarkers for Pancreatic Cysts
Park, W. G., Wu, M., Bowen, R., Zheng, M., Fitch, W. L., Pai, R. K., … Peltz, G. (2012). Diagnostic Utility of Metabolomic-Derived Biomarkers for Pancreatic Cysts. PANCREAS, 41(8), 1394–94.
-
Gallstone pancreatitis: why not cholecystectomy?
Worhunsky, D. J., & Visser, B. C. (2013). Gallstone pancreatitis: why not cholecystectomy? JAMA Surgery, 148(9), 872-?
-
Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis.
Kin, C., Kidess, E., Poultsides, G. A., Visser, B. C., & Jeffrey, S. S. (2013). Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis. Expert Review of Molecular Diagnostics, 13(6), 581–99.
-
Development of a transillumination infrared modality for differential vasoactive optical imaging
Dixit, S. S., Kim, H., Visser, B., & Faris, G. W. (2009). Development of a transillumination infrared modality for differential vasoactive optical imaging. APPLIED OPTICS, 48(10), D178–D186.
-
Reassessment of the Current American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Tumors
Qadan, M., Ma, Y., Visser, B. C., Kunz, P. L., Fisher, G. A., Norton, J. A., & Poultsides, G. A. (2014). Reassessment of the Current American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Tumors. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 218(2), 188–95.
-
Does chronic kidney disease affect outcomes after major abdominal surgery? Results from the national surgical quality improvement program.
Cloyd, J. M., Ma, Y., Morton, J. M., Kurella Tamura, M., Poultsides, G. A., & Visser, B. C. (2014). Does chronic kidney disease affect outcomes after major abdominal surgery? Results from the national surgical quality improvement program. Journal of Gastrointestinal Surgery , 18(3), 605–12.
-
Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness.
Worhunsky, D. J., Krampitz, G. W., Poullos, P. D., Visser, B. C., Kunz, P. L., Fisher, G. A., … Poultsides, G. A. (2014). Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness. HPB , 16(4), 304–11.
-
Postoperative serum amylase predicts pancreatic fistula formation following pancreaticoduodenectomy.
Cloyd, J. M., Kastenberg, Z. J., Visser, B. C., Poultsides, G. A., & Norton, J. A. (2014). Postoperative serum amylase predicts pancreatic fistula formation following pancreaticoduodenectomy. Journal of Gastrointestinal Surgery , 18(2), 348–53.
-
Locally advanced gastric cancer complicated by mesenteric invasion and intestinal malrotation.
Huang, R. J., Visser, B. C., Chen, A. M., & Ladabaum, U. (2014). Locally advanced gastric cancer complicated by mesenteric invasion and intestinal malrotation. Digestive Diseases and Sciences, 59(2), 267–69.
-
Man with hypoechoic lesion abutting the pancreas.
Krampitz, G. W., Mills, A. M., & Visser, B. C. (2014). Man with hypoechoic lesion abutting the pancreas. JAMA Surgery, 149(4), 393–94.
-
Getting the dead out: modern treatment strategies for necrotizing pancreatitis.
Dua, M. M., Worhunsky, D. J., Amin, S., Louie, J. D., Park, W. G., Triadafilopoulos, G., & Visser, B. C. (2014). Getting the dead out: modern treatment strategies for necrotizing pancreatitis. Digestive Diseases and Sciences, 59(9), 2069–75.
-
Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine
Park, W. G., Wu, M., Bowen, R., Zheng, M., Fitch, W. L., Pai, R. K., … Peltz, G. (2013). Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine. GASTROINTESTINAL ENDOSCOPY, 78(2), 295-?
-
Laparoscopic spleen-preserving distal pancreatectomy: the technique must suit the lesion.
Worhunsky, D. J., Zak, Y., Dua, M. M., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2014). Laparoscopic spleen-preserving distal pancreatectomy: the technique must suit the lesion. Journal of Gastrointestinal Surgery , 18(8), 1445–51.
-
Early vein reconstruction and right-to-left dissection for left-sided pancreatic tumors with portal vein occlusion.
Cloyd, J. M., Dua, M. M., & Visser, B. C. (2014). Early vein reconstruction and right-to-left dissection for left-sided pancreatic tumors with portal vein occlusion. Journal of Gastrointestinal Surgery , 18(11), 2034–37.
-
Non-MalIg(G4)nant Biliary Obstruction: When the Pill Is Mightier than the Knife
Dua, M. M., Qadan, M., Lutchman, G. A., Park, W. G., Triadafilopoulos, G., & Visser, B. C. (2015). Non-MalIg(G4)nant Biliary Obstruction: When the Pill Is Mightier than the Knife. DIGESTIVE DISEASES AND SCIENCES, 60(5), 1178–82.
-
More with Less: Pancreas-Preserving Total Duodenectomy
Qadan, M., Dua, M., Worhunsky, D., Triadafilopoulos, G., & Visser, B. (2015). More with Less: Pancreas-Preserving Total Duodenectomy. DIGESTIVE DISEASES AND SCIENCES, 60(6), 1565–68.
-
Laparoscopic Transgastric Necrosectomy for the Management of Pancreatic Necrosis
Worhunsky, D. J., Qadan, M., Dua, M. M., Park, W. G., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2014). Laparoscopic Transgastric Necrosectomy for the Management of Pancreatic Necrosis. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 219(4), 735–43.
-
Cardiac metastases and tumor embolization: A rare sequelae of primary undifferentiated liver sarcoma.
Dua, M. M., Cloyd, J. M., Haddad, F., Beygui, R. E., Norton, J. A., & Visser, B. C. (2014). Cardiac metastases and tumor embolization: A rare sequelae of primary undifferentiated liver sarcoma. International Journal of Surgery Case Reports, 5(12), 927–31.
-
Extracorporeal Pringle for laparoscopic liver resection
Dua, M. M., Worhunsky, D. J., Hwa, K., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2015). Extracorporeal Pringle for laparoscopic liver resection. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 29(6), 1348–55.
-
Single-versus Multifraction Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma: Outcomes and Toxicity
Pollom, E. L., Alagappan, M., von Eyben, R., Kunz, P. L., Fisher, G. A., Ford, J. A., … Chang, D. T. (2014). Single-versus Multifraction Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma: Outcomes and Toxicity. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90(4), 918–25.
-
Early Vein Reconstruction and Right-to-Left Dissection for Left-Sided Pancreatic Tumors with Portal Vein Occlusion
Cloyd, J. M., Dua, M. M., & Visser, B. C. (2014). Early Vein Reconstruction and Right-to-Left Dissection for Left-Sided Pancreatic Tumors with Portal Vein Occlusion. JOURNAL OF GASTROINTESTINAL SURGERY, 18(11), 2034–37.
-
Does the extent of resection impact survival for duodenal adenocarcinoma? Analysis of 1,611 cases.
Cloyd, J. M., Norton, J. A., Visser, B. C., & Poultsides, G. A. (2015). Does the extent of resection impact survival for duodenal adenocarcinoma? Analysis of 1,611 cases. Annals of Surgical Oncology, 22(2), 573–80.
-
Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform
Kidess, E., Heirich, K., Wiggin, M., Vysotskaia, V., Visser, B. C., Marziali, A., … Poultsides, G. A. (2015). Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform. ONCOTARGET, 6(4), 2549–61.
-
Compliance With Gastric Cancer Guidelines is Associated With Improved Outcomes.
Worhunsky, D. J., Ma, Y., Zak, Y., Poultsides, G. A., Norton, J. A., Rhoads, K. F., & Visser, B. C. (2015). Compliance With Gastric Cancer Guidelines is Associated With Improved Outcomes. Journal of the National Comprehensive Cancer Network , 13(3), 319–25.
-
Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing.
Kurtz, D. M., Green, M. R., Bratman, S. V., Scherer, F., Liu, C. L., Kunder, C. A., … Alizadeh, A. A. (2015). Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. Blood, 125(24), 3679–87.
-
Cyst Fluid Glucose is Rapidly Feasible and Accurate in Diagnosing Mucinous Pancreatic Cysts.
Zikos, T., Pham, K., Bowen, R., Chen, A. M., Banerjee, S., Friedland, S., … Park, W. G. (2015). Cyst Fluid Glucose is Rapidly Feasible and Accurate in Diagnosing Mucinous Pancreatic Cysts. American Journal of Gastroenterology, 110(6), 909–14.
-
Leiomyosarcoma: One Disease or Distinct Biologic Entities Based on Site of Origin?
Worhunsky, D. J., Gupta, M., Gholami, S., Tran, T. B., Ganjoo, K. N., van de Rijn, M., … Poultsides, G. A. (2015). Leiomyosarcoma: One Disease or Distinct Biologic Entities Based on Site of Origin? JOURNAL OF SURGICAL ONCOLOGY, 111(7), 808–12.
-
Severe acute pancreatitis in the community: confusion reigns
Dua, M. M., Worhunsky, D. J., Tran, T. B., Rumma, R. T., Poultsides, G. A., Norton, J. A., … Visser, B. C. (2015). Severe acute pancreatitis in the community: confusion reigns. JOURNAL OF SURGICAL RESEARCH, 199(1), 44–50.
-
Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma
Tran, T. B., Qadan, M., Dua, M. M., Norton, J. A., Poultsides, G. A., & Visser, B. C. (2015). Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma. SURGERY, 158(2), 486–93.
-
Hepato-pancreatectomy: how morbid? Results from the national surgical quality improvement project.
Tran, T. B., Dua, M. M., Spain, D. A., Visser, B. C., Norton, J. A., & Poultsides, G. A. (2015). Hepato-pancreatectomy: how morbid? Results from the national surgical quality improvement project. HPB , 17(9), 763–69.
-
Predictive Factors for Surgery Among Patients with Pancreatic Cysts in the Absence of High-Risk Features for Malignancy
Quan, S. Y., Visser, B. C., Poultsides, G. A., Norton, J. A., Chen, A. M., Banerjee, S., … Park, W. G. (2015). Predictive Factors for Surgery Among Patients with Pancreatic Cysts in the Absence of High-Risk Features for Malignancy. JOURNAL OF GASTROINTESTINAL SURGERY, 19(6), 1101–5.
-
Pancreatectomy with vein reconstruction: technique matters
Dua, M. M., Tran, T. B., Klausner, J., Hwa, K. J., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2015). Pancreatectomy with vein reconstruction: technique matters. HPB, 17(9), 824–31.
-
Hepato-pancreatectomy: how morbid? Results from the national surgical quality improvement project
Tran, T. B., Dua, M. M., Spain, D. A., Visser, B. C., Norton, J. A., & Poultsides, G. A. (2015). Hepato-pancreatectomy: how morbid? Results from the national surgical quality improvement project. HPB, 17(9), 763–69.
-
Primary Gastric Hodgkin's Lymphoma: An Extremely Rare Entity and A Diagnostic Challenge.
Sethi, S., Higgins, J. P., Arber, D. A., Visser, B., & Banerjee, S. (2015). Primary Gastric Hodgkin's Lymphoma: An Extremely Rare Entity and A Diagnostic Challenge. Digestive Diseases and Sciences, 60(10), 2923–26.
-
Laparoscopic transgastric necrosectomy for the management of pancreatic necrosis.
Worhunsky, D. J., Qadan, M., Dua, M. M., Park, W. G., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2014). Laparoscopic transgastric necrosectomy for the management of pancreatic necrosis. Journal of the American College of Surgeons, 219(4), 735–43.
-
Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity.
Pollom, E. L., Alagappan, M., von Eyben, R., Kunz, P. L., Fisher, G. A., Ford, J. A., … Chang, D. T. (2014). Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity. International Journal of Radiation Oncology, Biology, Physics, 90(4), 918–25.
-
Pancreatectomy with vein reconstruction: technique matters.
Dua, M. M., Tran, T. B., Klausner, J., Hwa, K. J., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2015). Pancreatectomy with vein reconstruction: technique matters. HPB , 17(9), 824–31.
-
Sarcoma Resection With and Without Vascular Reconstruction: A Matched Case-control Study
Poultsides, G. A., Tran, T. B., Zambrano, E., Janson, L., Mohler, D. G., Mell, M. W., … Norton, J. A. (2015). Sarcoma Resection With and Without Vascular Reconstruction: A Matched Case-control Study. ANNALS OF SURGERY, 262(4), 632–40.
-
Stereotactic body radiation therapy and central liver toxicity: A case report.
Shaffer, J. L., Osmundson, E. C., Visser, B. C., Longacre, T. A., Koong, A. C., & Chang, D. T. (2015). Stereotactic body radiation therapy and central liver toxicity: A case report. Practical Radiation Oncology, 5(5), 282–85.
-
Missing the obvious: psychosocial obstacles in Veterans with hepatocellular carcinoma
Hwa, K. J., Dua, M. M., Wren, S. M., & Visser, B. C. (2015). Missing the obvious: psychosocial obstacles in Veterans with hepatocellular carcinoma. HPB, 17(12), 1124–29.
-
The neurosurgical origins of image-guided surgery
Barrese, J. C., & Henderson, J. M. (2015). The neurosurgical origins of image-guided surgery. CURRENT PROBLEMS IN SURGERY, 52(12), 476–520.
-
Statin and Metformin Use Prolongs Survival in Patients With Resectable Pancreatic Cancer.
Kozak, M. M., Anderson, E. M., von Eyben, R., Pai, J. S., Poultsides, G. A., Visser, B. C., … Chang, D. T. (2016). Statin and Metformin Use Prolongs Survival in Patients With Resectable Pancreatic Cancer. Pancreas, 45(1), 64–70.
-
Management of Postoperative Hepatic Failure
Qadan, M., Garden, O. J., Corvera, C. U., & Visser, B. C. (2016). Management of Postoperative Hepatic Failure. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 222(2), 195–208.
-
Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors
Krampitz, G. W., George, B. M., Willingham, S. B., Volkmer, J.-P., Weiskopf, K., Jahchan, N., … Weissman, I. L. (2016). Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 113(16), 4464–69.
-
Image-guided surgery.
Azagury, D. E., Dua, M. M., Barrese, J. C., Henderson, J. M., Buchs, N. C., Ris, F., … Visser, B. C. (2015). Image-guided surgery. Current Problems in Surgery, 52(12), 476–520.
-
Neuroendocrine tumors of the pancreas: Degree of cystic component predicts prognosis.
Cloyd, J. M., Kopecky, K. E., Norton, J. A., Kunz, P. L., Fisher, G. A., Visser, B. C., … Poultsides, G. A. (2016). Neuroendocrine tumors of the pancreas: Degree of cystic component predicts prognosis. Surgery, 160(3), 708–13.
-
An economic analysis of pancreaticoduodenectomy: should costs drive consumer decisions?
Tran, T. B., Dua, M. M., Worhunsky, D. J., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2016). An economic analysis of pancreaticoduodenectomy: should costs drive consumer decisions? AMERICAN JOURNAL OF SURGERY, 211(6), 991-?
-
The First Decade of Laparoscopic Pancreaticoduodenectomy in the United States: Costs and Outcomes Using the Nationwide Inpatient Sample
Tran, T. B., Dua, M. M., Worhunsky, D. J., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2016). The First Decade of Laparoscopic Pancreaticoduodenectomy in the United States: Costs and Outcomes Using the Nationwide Inpatient Sample. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 30(5), 1778–83.
-
Biliary Cystadenoma: A Suggested "Cystamatic" Approach?
Dua, M. M., Gerry, J., Salles, A., Tran, T. B., Triadafilopoulos, G., & Visser, B. C. (2016). Biliary Cystadenoma: A Suggested "Cystamatic" Approach? DIGESTIVE DISEASES AND SCIENCES, 61(7), 1835–38.
-
The significance of underlying cardiac comorbidity on major adverse cardiac events after major liver resection.
Tran, T. B., Worhunsky, D. J., Spain, D. A., Dua, M. M., Visser, B. C., Norton, J. A., & Poultsides, G. A. (2016). The significance of underlying cardiac comorbidity on major adverse cardiac events after major liver resection. HPB , 18(9), 742–47.
-
Laparoscopic hepatectomy in cirrhotics: safe if you adjust technique.
Worhunsky, D. J., Dua, M. M., Tran, T. B., Siu, B., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2016). Laparoscopic hepatectomy in cirrhotics: safe if you adjust technique. Surgical Endoscopy, 30(10), 4307–14.
-
Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA
Scherer, F., Kurtz, D. M., Newman, A. M., Stehr, H., Craig, A. F. M., Esfahani, M. S., … Alizadeh, A. A. (2016). Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA. SCIENCE TRANSLATIONAL MEDICINE, 8(364).
-
Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer
Kidess-Sigal, E., Liu, H. E., Triboulet, M. M., Che, J., Ramani, V. C., Visser, B. C., … Jeffrey, S. S. (2016). Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer. ONCOTARGET, 7(51), 85349–64.
-
Recurrent Pyogenic Cholangitis: Got Stones?
Gholami, S., Wood, L., Berry, G., Triadafilopoulos, G., Visser, B. C., & Dua, M. M. (2016). Recurrent Pyogenic Cholangitis: Got Stones? Digestive Diseases and Sciences, 61(11), 3147–50.
-
Green Sludge: Intraductal Papillary Mucinous Neoplasm of the Bile Duct Presenting with Intermittent Biliary Obstruction Due to Abundant Mucus.
Choudhary, A., Barakat, M. T., Leal, J. N., Louie, C. Y., Visser, B. C., & Banerjee, S. (2016). Green Sludge: Intraductal Papillary Mucinous Neoplasm of the Bile Duct Presenting with Intermittent Biliary Obstruction Due to Abundant Mucus. Digestive Diseases and Sciences, -?
-
Validation of Fistula Risk Score calculator in diverse North American HPB practices.
Grendar, J., Jutric, Z., Leal, J. N., Ball, C. G., Bertens, K., Dixon, E., … Hansen, P. D. (2017). Validation of Fistula Risk Score calculator in diverse North American HPB practices. HPB .
-
Fukuoka and AGA Criteria Have Superior Diagnostic Accuracy for Advanced Cystic Neoplasms than Sendai Criteria.
Sighinolfi, M., Quan, S. Y., Lee, Y., Ibaseta, A., Pham, K., Dua, M. M., … Park, W. G. (2017). Fukuoka and AGA Criteria Have Superior Diagnostic Accuracy for Advanced Cystic Neoplasms than Sendai Criteria. Digestive Diseases and Sciences, 62(3), 626–32.
-
Duodenal adenocarcinoma: Advances in diagnosis and surgical management.
Cloyd, J. M., George, E., & Visser, B. C. (2016). Duodenal adenocarcinoma: Advances in diagnosis and surgical management. World Journal of Gastrointestinal Surgery, 8(3), 212–21.
-
Surgical Approaches to Chronic Pancreatitis: Indications and Techniques.
Dua, M. M., & Visser, B. C. (2017). Surgical Approaches to Chronic Pancreatitis: Indications and Techniques. Digestive Diseases and Sciences.
-
Development and Validation of Biopsy-Free Genotyping for Molecular Subtyping of Diffuse Large B-Cell Lymphoma
Scherer, F., Kurtz, D. M., Newman, A. M., Esfahani, M. S., Craig, A., Stehr, H., … Alizadeh, A. A. (2016). Development and Validation of Biopsy-Free Genotyping for Molecular Subtyping of Diffuse Large B-Cell Lymphoma. BLOOD, 128(22).
-
Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center
Porter, J. B. (2017). Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center. Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center, 13(8), e673–e682.
-
When Lightning Strikes Twice.
Baiu, I., Charville, G. W., & Visser, B. C. (2018). When Lightning Strikes Twice. Digestive Diseases and Sciences.
-
Prospective Evaluation of Results of Reoperation in Zollinger-Ellison Syndrome.
Norton, J. A., Krampitz, G. W., Poultsides, G. A., Visser, B. C., Fraker, D. L., Alexander, H. R., & Jensen, R. T. (2018). Prospective Evaluation of Results of Reoperation in Zollinger-Ellison Syndrome. Annals of Surgery, 267(4), 782–88.
-
Incidence and Prognosis of Primary Gastrinomas in the Hepatobiliary Tract
Norton, J. A., Foster, D. S., Blumgart, L. H., Poultsides, G. A., Visser, B. C., Fraker, D. L., … Jensen, R. T. (2018). Incidence and Prognosis of Primary Gastrinomas in the Hepatobiliary Tract. JAMA SURGERY, 153(3), e175083.
-
Management of Borderline Resectable Pancreatic Cancer.
Toesca, D. A., Koong, A. J., Poultsides, G. A., Visser, B. C., Haraldsdottir, S., Koong, A. C., & Chang, D. T. (2018). Management of Borderline Resectable Pancreatic Cancer. International Journal of Radiation Oncology, Biology, Physics, 100(5), 1155–74.
-
Prediction of pancreatic cancer surgical outcomes and prognosis based on an objective resectability scoring system
Toesca, D. A. S., Jeffrey, B., von Eyben, R., Poullos, P. D., Poultsides, G. A., Fisher, G. A., … Chang, D. T. (2018). Prediction of pancreatic cancer surgical outcomes and prognosis based on an objective resectability scoring system. Journal of Clinical Oncology, 36(4_suppl), 446.
-
The Effect of Chronic Kidney Disease on Postoperative Outcomes after Major Hepatectomy: Results from the National Surgical Quality Improvement Program
Tran, T. B., Dua, M. M., Spain, D. A., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2015). The Effect of Chronic Kidney Disease on Postoperative Outcomes after Major Hepatectomy: Results from the National Surgical Quality Improvement Program. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 221(4), S94–S95.
-
Noninvasive Genotyping and Assessment of Treatment Response in Diffuse Large B Cell Lymphoma
Scherer, F., Kurtz, D. M., Newman, A. M., Stehr, H., Liu, C. L., Zhou, L., … Alizadeh, A. A. (2015). Noninvasive Genotyping and Assessment of Treatment Response in Diffuse Large B Cell Lymphoma. BLOOD, 126(23).
-
Pretreatment lab values to predict overall survival in patients with primary unresectable pancreatic adenocarcinoma treated with SBRT
Alagappan, M., Pollom, E. L., von Eyben, R., Kunz, P. L., Fisher, G. A., Ford, J. M., … Chang, D. T. (2015). Pretreatment lab values to predict overall survival in patients with primary unresectable pancreatic adenocarcinoma treated with SBRT. JOURNAL OF CLINICAL ONCOLOGY, 33(3).
-
Transgastric pancreatic necrosectomy-expedited return to prepancreatitis health
Dua, M. M., Worhunsky, D. J., Malhotra, L., Park, W. G., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2017). Transgastric pancreatic necrosectomy-expedited return to prepancreatitis health. JOURNAL OF SURGICAL RESEARCH, 219, 11–17.
-
Minimally invasive approaches to resection of benign/low-grade gastric tumors
Salles, A., Dua, M., Friedland, S., & Visser, B. (2016). Minimally invasive approaches to resection of benign/low-grade gastric tumors. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 30(6), 2624–25.
-
Hepato-pancreatectomy: perioperative and long term outcomes of synchronous hepatic and pancreatic resection
Tran, T. B., Dua, M. M., Visser, B. C., Norton, J. A., & Poultsides, G. A. (2015). Hepato-pancreatectomy: perioperative and long term outcomes of synchronous hepatic and pancreatic resection. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 221(4), E95.
-
Management of Postoperative Pancreatic Fistula: Drain Position Matters
Malhotra, L., Dua, M. M., Leal, J. N., Poultsides, G. A., Norton, J. A., & Visser, B. C. (2017). Management of Postoperative Pancreatic Fistula: Drain Position Matters. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 225(4), E123–E124.
-
Surgical Strategies for the Management of Necrotizing Pancreatitis
Dua, M. M., Worhunsky, D. J., Tran, T. B., Friedland, S., Park, W. G., & Visser, B. C. (2015). Surgical Strategies for the Management of Necrotizing Pancreatitis. JOURNAL OF THE PANCREAS, 16(6), 547–58.
-
Monitoring Gastric Myoelectric Activity After Pancreaticoduodenectomy for Diet "Readiness".
Dua, M. M., Navalgund, A., Axelrod, S., Axelrod, L., Worth, P. J., Norton, J. A., … Visser, B. C. (2018). Monitoring Gastric Myoelectric Activity After Pancreaticoduodenectomy for Diet "Readiness". American Journal of Physiology. Gastrointestinal and Liver Physiology.
-
Surgical and molecular characterization of primary and metastatic disease in a neuroendocrine tumor arising in a tailgut cyst.
Erdrich, J., Schaberg, K., Khodadoust, M. S., Zhou, L., Shelton, A. A., Visser, B. C., … Beausang, J. F. (2018). Surgical and molecular characterization of primary and metastatic disease in a neuroendocrine tumor arising in a tailgut cyst. Cold Spring Harbor Molecular Case Studies.
-
Noninvasive Detection of BCL2, BCL6, and MYC Translocations in Diffuse Large B-Cell Lymphoma
Kurtz, D. M., Scherer, F., Newman, A. M., Craig, A., Jin, M., Stehr, H., … Alizadeh, A. A. (2016). Noninvasive Detection of BCL2, BCL6, and MYC Translocations in Diffuse Large B-Cell Lymphoma. BLOOD, 128(22).
-
Isolated pancreatic tail remnants after transgastric necrosectomy can be observed.
Dua, M. M., Jensen, C. W., Friedland, S., Worth, P. J., Poultsides, G. A., Norton, J. A., … Visser, B. C. (2018). Isolated pancreatic tail remnants after transgastric necrosectomy can be observed. The Journal of Surgical Research, 231, 109–15.
-
Circulating tumor DNA (ctDNA) in B-cell lymphoma
Scherer, F., Kurtz, D. M., Newman, A. M., Stehr, H., Craig, A. F. M., Esfahani, M. S., … Alizadeh, A. A. (2018). Circulating tumor DNA (ctDNA) in B-cell lymphoma. BRITISH JOURNAL OF HAEMATOLOGY, 182, 16–17.
-
Ruptured Oncocytic Intraductal Papillary Neoplasm: Think Beyond the Pancreas.
Jensen, C. W., Worhunsky, D. J., Triadafilopoulos, G., Bingham, D. B., & Visser, B. C. (2019). Ruptured Oncocytic Intraductal Papillary Neoplasm: Think Beyond the Pancreas. Digestive Diseases and Sciences.
-
Minimally Invasive Small Bowel Cancer Surgery.
Baiu, I., & Visser, B. C. (2019). Minimally Invasive Small Bowel Cancer Surgery. Surgical Oncology Clinics of North America, 28(2), 273–83.
-
Identification of Tumorigenic Cells and Therapeutic Targets in Pancreatic Neuroendocrine Cancers
Krampitz, G. W., Willingham, S. B., Volkmer, J. P., Weiskopf, K. A., George, B. M., Sage, J., … Weissman, I. L. (2015). Identification of Tumorigenic Cells and Therapeutic Targets in Pancreatic Neuroendocrine Cancers. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 221(4), S59–S60.
-
Performance of a novel TNM staging system for pancreatic neuroendocrine tumors versus the current AJCC staging system
Qadan, M., Ma, Y., Visser, B. C., Norton, J. A., & Poultsides, G. A. (2013). Performance of a novel TNM staging system for pancreatic neuroendocrine tumors versus the current AJCC staging system. JOURNAL OF CLINICAL ONCOLOGY, 31(4).
-
Shades of 'Childs A': successful laparoscopic major hepatectomies in cirrhotics
Worth, P. J., & Visser, B. C. (2017). Shades of 'Childs A': successful laparoscopic major hepatectomies in cirrhotics. ANNALS OF LAPAROSCOPIC AND ENDOSCOPIC SURGERY, 2.
-
Surgical Transgastric Necrosectomy for Necrotizing Pancreatitis: A Single-stage Procedure for Walled-off Pancreatic Necrosis.
Driedger, M., Zyromski, N. J., Visser, B. C., Jester, A., Sutherland, F. R., Nakeeb, A., … Ball, C. G. (2018). Surgical Transgastric Necrosectomy for Necrotizing Pancreatitis: A Single-stage Procedure for Walled-off Pancreatic Necrosis. Annals of Surgery.
-
Colorectal liver metastases management in the Veterans Health Administration: Geographic disparity.
Mobarek, D. A., Visser, B. C., Krasnow, S., Chang, J. W., Nechodom, P., & DuVall, S. L. (2016). Colorectal liver metastases management in the Veterans Health Administration: Geographic disparity. JOURNAL OF CLINICAL ONCOLOGY, 34(4).
-
Management of colorectal hepatic met stases in the Veterans Affairs medical system: Opportunities for curative intent surgery
Mobarek, D. A., Visser, B. C., Freeman, A., Bentt, D., Ayvazian, J., Maron, D., … Krasnow, S. (2014). Management of colorectal hepatic met stases in the Veterans Affairs medical system: Opportunities for curative intent surgery. JOURNAL OF CLINICAL ONCOLOGY, 32(15).
-
Nullius in Verba INVITED CRITIQUE
Visser, B. C. (2013). Nullius in Verba INVITED CRITIQUE. JAMA SURGERY, 148(3), 257–58.
-
Sarcoma Resection With and Without Vascular Reconstruction: A Matched Case-control Study.
Poultsides, G. A., Tran, T. B., Zambrano, E., Janson, L., Mohler, D. G., Mell, M. W., … Norton, J. A. (2015). Sarcoma Resection With and Without Vascular Reconstruction: A Matched Case-control Study. Annals of Surgery, 262(4), 632–40.
-
Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma.
Tran, T. B., Qadan, M., Dua, M. M., Norton, J. A., Poultsides, G. A., & Visser, B. C. (2015). Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinoma. Surgery, 158(2), 486–93.
-
Missing the obvious: psychosocial obstacles in Veterans with hepatocellular carcinoma.
Hwa, K. J., Dua, M. M., Wren, S. M., & Visser, B. C. (2015). Missing the obvious: psychosocial obstacles in Veterans with hepatocellular carcinoma. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
-
Management of Postoperative Hepatic Failure.
Qadan, M., Garden, O. J., Corvera, C. U., & Visser, B. C. (2016). Management of Postoperative Hepatic Failure. Journal of the American College of Surgeons, 222(2), 195–208.
-
Improving care with portfolio of physician-led cancer quality measures at an academic center
Porter, J., Smith, A. S., Winget, M., Rosenthal, E. L., Seshadri, S. B., Vetteth, Y., … Blayney, D. W. (2017). Improving care with portfolio of physician-led cancer quality measures at an academic center. JOURNAL OF CLINICAL ONCOLOGY, 35(8).
-
Prospective Evaluation of Results of Reoperation in Zollinger-Ellison Syndrome
Norton, J. A., Krampitz, G. W., Poultsides, G. A., Visser, B. C., Fraker, D. L., Alexander, H. R., & Jensen, R. T. (2018). Prospective Evaluation of Results of Reoperation in Zollinger-Ellison Syndrome. ANNALS OF SURGERY, 267(4), 782–88.
-
Surgical and molecular characterization of primary and metastatic disease in a neuroendocrine tumor arising in a tailgut cyst
Erdrich, J., Schaberg, K. B., Khodadoust, M. S., Zhou, L., Shelton, A. A., Visser, B. C., … Beausang, J. F. (2018). Surgical and molecular characterization of primary and metastatic disease in a neuroendocrine tumor arising in a tailgut cyst. COLD SPRING HARBOR MOLECULAR CASE STUDIES, 4(5).
-
Isolated pancreatic tail remnants after transgastric necrosectomy can be observed
Dua, M. M., Jensen, C. W., Friedland, S., Worth, P. J., Poultsides, G. A., Norton, J. A., … Visser, B. C. (2018). Isolated pancreatic tail remnants after transgastric necrosectomy can be observed. JOURNAL OF SURGICAL RESEARCH, 231, 109–15.
-
Monitoring gastric myoelectric activity after pancreaticoduodenectomy for diet "readiness"
Dua, M. M., Navalgund, A., Axelrod, S., Axelrod, L., Worth, P. J., Norton, J. A., … Visser, B. C. (2018). Monitoring gastric myoelectric activity after pancreaticoduodenectomy for diet "readiness". AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 315(5), G743–G751.
-
When Lightning Strikes Twice
Baiu, I., Charville, G. W., & Visser, B. C. (2018). When Lightning Strikes Twice. DIGESTIVE DISEASES AND SCIENCES, 63(10), 2536–40.
-
Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System.
Toesca, D. A., Jeffrey, R. B., von Eyben, R., Pollom, E. L., Poullos, P. D., Poultsides, G. A., … Chang, D. T. Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System. Pancreas, 48(5), 622–28.
-
Ruptured Oncocytic Intraductal Papillary Neoplasm: Think Beyond the Pancreas
Jensen, C. W., Worhunsky, D. J., Triadafilopoulos, G., Bingham, D. B., & Visser, B. C. (2019). Ruptured Oncocytic Intraductal Papillary Neoplasm: Think Beyond the Pancreas. DIGESTIVE DISEASES AND SCIENCES, 64(6), 1436–38.
-
Management of Ileal Neuroendocrine Tumors with Liver Metastases.
Fisher, A. T., Titan, A. L., Foster, D. S., Worth, P. J., Poultsides, G. A., Visser, B. C., … Norton, J. A. (2019). Management of Ileal Neuroendocrine Tumors with Liver Metastases. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract.
-
Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System
Toesca, D. A. S., Jeffrey, R. B., von Eyben, R., Pollom, E. L., Poullos, P. D., Poultsides, G. A., … Chang, D. T. (2019). Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System. PANCREAS, 48(5), 622–28.
-
Minimally Invasive Small Bowel Cancer Surgery
Baiu, I., & Visser, B. C. (2019). Minimally Invasive Small Bowel Cancer Surgery. SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 28(2), 273-+.
-
Evaluation of integrin alphavbeta6 cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis.
Kimura, R. H., Wang, L., Shen, B., Huo, L., Tummers, W., Filipp, F. V., … Gambhir, S. S. (2019). Evaluation of integrin alphavbeta6 cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis. Nature Communications, 10(1), 4673.
-
Postoperative Outcomes of Laparoscopic vs Robotic Distal Pancreatectomy: A Propensity-Matched Analysis
Jensen, C. W., Baiocchi, M., Dua, M. M., Poultsides, G. A., Norton, J. A., Worth, P. J., & Visser, B. C. (2019). Postoperative Outcomes of Laparoscopic vs Robotic Distal Pancreatectomy: A Propensity-Matched Analysis. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 229(4), S181–S182.
-
Pancreatic grade 3 neuroendocrine tumors behave similarly to neuroendocrine carcinomas following resection: a multi-center, international appraisal of the WHO 2010 and WHO 2017 staging schema for pancreatic neuroendocrine lesions.
Worth, P. J., Leal, J., Ding, Q., Trickey, A., Dua, M. M., Chatzizacharias, N., … Visser, B. C. (2020). Pancreatic grade 3 neuroendocrine tumors behave similarly to neuroendocrine carcinomas following resection: a multi-center, international appraisal of the WHO 2010 and WHO 2017 staging schema for pancreatic neuroendocrine lesions. HPB : the Official Journal of the International Hepato Pancreato Biliary Association.
-
Neoadjuvant Capecitabine/Temozolomide for Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors.
Squires, M. H., Worth, P. J., Konda, B., Shah, M. H., Dillhoff, M. E., Abdel-Misih, S., … Cloyd, J. M. (2020). Neoadjuvant Capecitabine/Temozolomide for Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors. Pancreas.
-
Questionable Survival Benefit of Aspirin Use in Patients With Biliary Tract Cancer.
Bergquist, J. R., Shariq, O. A., & Visser, B. C. (2020). Questionable Survival Benefit of Aspirin Use in Patients With Biliary Tract Cancer. JAMA Oncology.
-
Minimally invasive options for gastrointestinal stromal tumors of the stomach.
Mazer, L., Worth, P., & Visser, B. (2020). Minimally invasive options for gastrointestinal stromal tumors of the stomach. Surgical Endoscopy.
-
Nearing the Summit: Associating Liver Partitioning and Portal Ligation for Staged Hepatectomy (ALPPS) in Progressive Carcinoid Disease.
Bergquist, J. R., Li, A. Y., Chang, E. M., Scott, G. D., Dua, M. M., & Visser, B. C. (2020). Nearing the Summit: Associating Liver Partitioning and Portal Ligation for Staged Hepatectomy (ALPPS) in Progressive Carcinoid Disease. Digestive Diseases and Sciences.
-
Surgical Transgastric Necrosectomy for Necrotizing Pancreatitis A Single-stage Procedure for Walled-off Pancreatic Necrosis
Driedger, M., Zyromski, N. J., Visser, B. C., Jester, A., Sutherland, F. R., Nakeeb, A., … Ball, C. G. (2020). Surgical Transgastric Necrosectomy for Necrotizing Pancreatitis A Single-stage Procedure for Walled-off Pancreatic Necrosis. ANNALS OF SURGERY, 271(1), 163–68.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Patient Comments
Patients comments are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
SHC Patient, Jan 2020
Dr. Visser is exceptional, very thorough, very caring and the best.
SHC Patient, Jan 2020
First comes into room and states rather abruptly I don't like your pulmonary function.
SHC Patient, Dec 2019
Utmost trust in Dr. Visser. Couldn't have a BETTER doctor.
SHC Patient, Dec 2019
Dr Visser saver my life!
SHC Patient, Dec 2019
When I asked about my CT scan, I was told not to worry about it. He said the other doctors do not know how to read them. He asked me if I had any questions. I asked him about one of the things that was on the CT scan and again he told me that the person that wrote about what they saw on the scan did not know how to read it. He never explained why. I left wondering why three other doctors, that do not know each other came up with the same conclusion. I tried to tell him that something else is going on but he said that everything is good with me and not to worry. That is hard to do when I am feeling sick.
SHC Patient, Dec 2019
Drs. were knowledgeable and explained things well. The only negative aspect was that Dr. Visser was continually paged and had to take a phone call during my appointment.
SHC Patient, Dec 2019
good
SHC Patient, Dec 2019
Dr. Visser explains everything and cares very much.
SHC Patient, Dec 2019
Dr. Visser was EXCELLENT in every way.
SHC Patient, Oct 2019
Dr. Visser is clearly an expert in his field, and he was honest and straightforward with me about not knowing what kind of mass I had, despite that being difficult news. He & his staff recognized that they could help me sooner rather than later & worked to make that happen.
SHC Patient, Oct 2019
I am in good hands. Am very happy I came to Stanford.
SHC Patient, Sep 2019
They rush in late & rush out immediately... having someone else come in... very unorganized or lack of communication.
SHC Patient, Sep 2019
Very good.
SHC Patient, Sep 2019
Quality of care at Stanford has been outstanding.
SHC Patient, Sep 2019
Dr. Visser is a caring, excellent physician who is an asset to your hospital. He is very knowledgeable & is very professional in dealing with his patients. I am so blessed to have him as my surgeon/oncologist.
SHC Patient, Sep 2019
on this particular visit I felt the Dr. Visser was rushed and not fully engaged with me.
SHC Patient, Aug 2019
Excellence!
SHC Patient, Aug 2019
Was final follow-up visit. Dr. Visser has been a "life saver." A pleasure to have been his patient.
SHC Patient, Jun 2019
Excellent physicians & NP. Very detailed and compassionate and concerned about getting me immediate care. Also called me at home to keep me updated.
SHC Patient, Jun 2019
Dr. Visser and his PA (Kristen?) were personable and professional to a fault. I couldn't have asked for a better care team.
SHC Patient, Jun 2019
I am very confident in Dr. Visser and his team of experts.
SHC Patient, May 2019
Dr. Visser & Dr. Basina are the best in there fields worth my having to drive 50 miles to see them.
SHC Patient, May 2019
Dr. Visser and Kristen Wheeler were exceptionally helpful and articulate in explaining my symptoms and procedure needed.
SHC Patient, May 2019
Excellent experience at all my appointments and treatment.
SHC Patient, Apr 2019
Dr. Visser and his team are excellent! They are very knowledgeable and explain everything to me in a way that I can understand fully.
SHC Patient, Mar 2019
I can always depend on Dr Visser and his team are there for me with the answers and corrective action
SHC Patient, Mar 2019
Dr. Visser, Kristan Wheeler, Taylor Foyel, Monica Dua and all of Dr. Visser staff were very kind and friendly! Best office experience I ever had.
SHC Patient, Feb 2019
Dr, Visser did not share any information I did not know. Did not offer any recommendation other than surgery as expected. More in depth analysis of my unique condition would have been helpful. Statistics in probability of progression on my pancreatic NET was missing.
SHC Patient, Feb 2019
I think that Stanford Health Care is the best we have in California all excellent.
SHC Patient, Feb 2019
great. great. great wonderful doctor
SHC Patient, Feb 2019
Dr. Visser was AMAZING!!
SHC Patient, Jan 2019
Everyone was nice and caring and made me comfortable and understand about my physical condition. Dr. Visser is good and knowledgeable person. I would highly recommend to others.
SHC Patient, Jan 2019
I feel blessed that Dr. Visser took me in as a patient. he has been working to correct damage implemented by a previous hospital. I am not sure where my health would have ended up without his expertise - Very grateful.
SHC Patient, Dec 2018
Dr. Visser was amazing. He answered all our questions & concerns... He was very kind. His PA that saw us the first day was amazing helped with drsg. D & skin.
SHC Patient, Dec 2018
I am still confused about the information from the consultation, and I can't find a way to get questions answered. I think Dr. Visser is an excellent surgeon, but I will probably either cancel or delay the surgery. Also, if they won't respond to phone calls now, and I had a problem after surgery, would they respond them? Maybe not.
SHC Patient, Oct 2018
Dr Visser had review my case before entering the exam room. He put me at ease and instilled confidence that he is competent and knowledgeable surgeon.
SHC Patient, Oct 2018
Very good.
SHC Patient, Aug 2018
Post surgery, this was my 4th year meeting with Dr. Vissor. We always have a lively discussion. He help save my life in a big way!
SHC Patient, Jul 2018
Dr. Visser inspires confidence.
SHC Patient, Jul 2018
Dr. Visser is an asset to Stanford Health Care. He is an excellent physician with good bedside manner. Very professional, knowledgeable and very compassionate. I am so lucky to have him as my onco/surgeon. He saved my life!
SHC Patient, Jul 2018
excellent
SHC Patient, Jun 2018
excellent
SHC Patient, Jun 2018
I like Dr Visser & his assist, overall, good experience.
SHC Patient, May 2018
I am cancer free and alive today because of Dr. Visser. the only doctor after seeing so many who diagnosed my cancer and had the capability of performing my surgery
SHC Patient, May 2018
Could not have been a better experience totally being treated by Dr. Visser and his PAs Kristen and Tanya.
SHC Patient, May 2018
good
SHC Patient, May 2018
There was some use of medical jargon for which I had to stop the provider and ask for a clarification.
SHC Patient, May 2018
Dr. Visser great clinician!
SHC Patient, Mar 2018
Excellent! Thank you!
SHC Patient, Jan 2018
This was just a short follow - up, that gave me confidence in my body's healing. Dr. Visser is a terrific physician & relates well to the patient.
SHC Patient, Jan 2018
All good.
SHC Patient, Jan 2018
care provider very easy to understand and very thorough
SHC Patient, Jan 2018
Excellent experience!
SHC Patient, Dec 2017
Surgeon was highly recommended to me by oncologist at PAMF. Nothing in subsequent appointments w/this doctor altered my impression of this surgeon.
SHC Patient, Dec 2017
I have total confidence in Dr. Visser. If I were asked where I wanted to go if I had to go the hospital; it would be Stanford.
SHC Patient, Oct 2017
My high marks are made without reservation. I cannot imagine better care from all levels. Thank you.
SHC Patient, Oct 2017
Always was put a ease. All test results were carefully explained. I always felt very good after each visit.
SHC Patient, Sep 2017
the information was both refreshing and a bit daunting as I have a rare problem and the surgeon recommended a second surgery to deal with the problem.
SHC Patient, Aug 2017
PA went over CT scans with us & explained very clearly.
SHC Patient, Jul 2017
Provider was just wonderful
SHC Patient, Jul 2017
Actual time spent with Dr. Visser helpful! Good explanations & answered all questions satisfactorily.
SHC Patient, Jun 2017
Thank you again!
SHC Patient, Jun 2017
no bad experience
SHC Patient, Mar 2017
I will gladly recommend both Dr. Visser and Dr. Heestand and their PA to Friends and Family
SHC Patient, Mar 2017
World's best doctor thank God for him.
SHC Patient, Jan 2017
Doctor was a bit distant, hurried, not engaged with me as an individual (but, not unusual for a surgeon).
SHC Patient, Jan 2017
Dr. Visser explained very clearly & answered all questions we had.
SHC Patient, Jan 2017
Always the best of care.
SHC Patient, Jan 2017
Dr Visser is a very nice man who can come down to your level and explain to you what he thinks. He is very good at being honest and providing you with any choice there may be. I liked his style very much. He knows people come to see him and they are nervous I believe Dr Visser realizes this and shows care and kindness yet he does give you the feeling he is very confidant but in a good way NOT an arrogant way.
SHC Patient, Nov 2016
Dr. Visser impresses me with his knowledge and expertise in his field. He makes me feel very comfortable and at easy when talking to him about my condition. He tends to explain things in easy to underst terms without feeling you are being talked down to.
SHC Patient, Oct 2016
Dr. Visser & his staff are awesome!
SHC Patient, Oct 2016
I consider Dr. Visser to be highly capable and kind. He has my utmost respect.
SHC Patient, Oct 2016
Dr. Visser carefully listened to my questions and gave complete and thoughtful answers.
SHC Patient, Oct 2016
Good experience.
SHC Patient, Sep 2016
Dr. Visser explained everything.
SHC Patient, Jul 2016
All are special, make me feel very good.
SHC Patient, Jul 2016
excellent!!!!
SHC Patient, Jun 2016
Dr. Visser listened carefully, explained what was going to happen in my surgery, and answered every question I asked.
SHC Patient, Apr 2016
Dr. Visser is the best!! Exceeds expectations! Friendly, knowledgeable, concerned. I tell everyone how wonderful he is.
SHC Patient, Apr 2016
All the doctors and nurses and people from the office and they are very friendly and attentive.
SHC Patient, Apr 2016
I feel very lucky to have Dr Visser and his staff as my health providers for my recent surgery.
SHC Patient, Apr 2016
I dont have any words to explain the level of care that my doctor has provided me. Its top notch..five star.
SHC Patient, Mar 2016
Dr. Visser saved my life. I went months of tests surgical procedures at Sutter Medical and not one doctor knew what was wrong. I had a death sentence until I found Dr. Visser.
SHC Patient, Feb 2016
I feel that I am in very competent hands and could not ask for more.
SHC Patient, Jan 2016
Dr. Visser highly experienced doctor. Very courteous, politeness, friendliness. I never see doctor like dr. Visser in my life. God will give long life.
SHC Patient, Jan 2016
Excellence.
SHC Patient, Nov 2015
Good
SHC Patient, Oct 2015
Dr. Visser was the first professional after seeing many doctors that came in and told me exactly what my health issue was and how to proceed. He explained every detail of what needed to be done leading up to my surgery in preparation to the details of the surgery. Dr. Visser takes his time and explains everything in a way that a person who is not a doctor can understand. he cares about his patients and his work.
SHC Patient, Aug 2015
I get respect and kindness there.
SHC Patient, Jul 2015
My husband and I felt like members of the treatment team and that we participated in determining the treatment plan. I wasn't told, this is what we are going to do.
SHC Patient, Jul 2015
Excellent.
SHC Patient, Jun 2015
Dr. Visser & Dr. Kunz were prepared, direct and knowledgeable. Excellent experience.
SHC Patient, Jun 2015
Good experience in everything.
SHC Patient, Jun 2015
Highly recommend Dr. Visser to any friends/family.
SHC Patient, May 2015
Dr. Visser is the best!!! I completely trust him.
SHC Patient, Apr 2015
I was more relaxed after speaking with the doctor.
SHC Patient, Mar 2015
Provider was very knowledgeable and answered all questions.
SHC Patient, Mar 2015
Both the NP & Dr. Visser were very thorough & made me feel comfortable.
SHC Patient, Mar 2015
Outstanding.
SHC Patient, Feb 2015
Visser is an outstanding surgeon! Never had to take pain medications.
SHC Patient, Jan 2015
Excellent saved my life.
SHC Patient, Nov 2014
Dr. Visser was excellent. Worth waiting for.
SHC Patient, Oct 2014
Good care was provided.
SHC Patient, Sep 2014
I consulted w/Dr. Visser briefly for a second opinion; he was professional - but brief - I decided to go elsewhere for my care -
SHC Patient, Aug 2014
He is very knowledgeable, very personable & confidence puts you @ ease. Might be helpful to check in with patient before or after surgery.
SHC Patient, Jul 2014
All good.
SHC Patient, Jul 2014
I feel as if I am in great hands with Dr. Visser.
SHC Patient, Jul 2014
Dr. Visser & his PA and all are Life savers and awesome.
SHC Patient, Jun 2014
PA was very good. Vissar is great once he arrived.
SHC Patient, May 2014
I appreciate my care provider, Dr. Brendan Visser. The way I look at him, he is sincere, kind and understanding.
SHC Patient, May 2014
Dr Visser was so good, friendly knowledgeable and reassuring.
SHC Patient, May 2014
I am not sure how I feel about this provider. I have had less than 15 minutes of interaction with them it is hard to determine how I feel.
SHC Patient, Mar 2014
My experience was comfortable with the provider & his staff.
SHC Patient, Jan 2014
Great dr. I will recommend.
SHC Patient, Jan 2014
Great doctor! Given encouragements & hope which are importance during difficult time & recovery.
SHC Patient, Jan 2020
Dr. Visser is exceptional, very thorough, very caring and the best.
SHC Patient, Jan 2020
First comes into room and states rather abruptly I don't like your pulmonary function.
SHC Patient, Dec 2019
Utmost trust in Dr. Visser. Couldn't have a BETTER doctor.
SHC Patient, Dec 2019
Dr Visser saver my life!
SHC Patient, Dec 2019
When I asked about my CT scan, I was told not to worry about it. He said the other doctors do not know how to read them. He asked me if I had any questions. I asked him about one of the things that was on the CT scan and again he told me that the person that wrote about what they saw on the scan did not know how to read it. He never explained why. I left wondering why three other doctors, that do not know each other came up with the same conclusion. I tried to tell him that something else is going on but he said that everything is good with me and not to worry. That is hard to do when I am feeling sick.
SHC Patient, Dec 2019
Drs. were knowledgeable and explained things well. The only negative aspect was that Dr. Visser was continually paged and had to take a phone call during my appointment.
SHC Patient, Dec 2019
good
SHC Patient, Dec 2019
Dr. Visser explains everything and cares very much.
SHC Patient, Dec 2019
Dr. Visser was EXCELLENT in every way.
SHC Patient, Oct 2019
Dr. Visser is clearly an expert in his field, and he was honest and straightforward with me about not knowing what kind of mass I had, despite that being difficult news. He & his staff recognized that they could help me sooner rather than later & worked to make that happen.
SHC Patient, Oct 2019
I am in good hands. Am very happy I came to Stanford.
SHC Patient, Sep 2019
They rush in late & rush out immediately... having someone else come in... very unorganized or lack of communication.
View All 115 Patient Comments »